Genetic testing for hereditary breast cancer in Poland: 1998-2022.
Hered Cancer Clin Pract
; 21(1): 9, 2023 Jun 13.
Article
in En
| MEDLINE
| ID: mdl-37312208
ABSTRACT
BRCA1 and BRCA2 mutations contribute to both breast cancer and ovarian cancer worldwide. In Poland approximately 4% of patients with breast cancers and 10% of patients with ovarian cancer carry a mutation in BRCA1. The majority of mutations consist of three founder mutations. A rapid inexpensive test for these three mutations can be used to screen all Polish adults at a reasonable cost. In the region of Pomerania of North-western Poland nearly half a million tests have been performed, in large part through engaging family doctors and providing ready access to testing through the Pomeranian Medical University. The following commentary provides a history of genetic testing for cancer in Pomerania and the current approach to facilitating access to genetic testing at the Cancer Family Clinic for all adults living in the region.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Hered Cancer Clin Pract
Year:
2023
Document type:
Article
Affiliation country:
Polonia